Oral Semaglutide: Dosage in Special Situations View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2022-05-07

AUTHORS

Sanjay Kalra, Nitin Kapoor

ABSTRACT

Glucagon-like peptide 1 receptor agonists (GLP1RAs) have recently gained momentum after the introduction of semaglutide, the first oral molecule in their class. In a recent article in this journal by Evans et al., a succinct overview of the utility of semaglutide is highlighted in the context of virtual diabetes care. To take this discussion further, this commentary describes the value and positioning of oral semaglutide in common clinical situations. Its insights assist in pragmatic placement of this drug in clinical practice. Special emphasis is laid on the use of oral semaglutide in persons already on injectable GLP-1RA formulations, those experiencing sudden changes in life style pattern due to religious, social, or professional commitments, individuals seeking help for urgent glycemic control, and those who face sudden change in their concomitant medications or comorbidities. More... »

PAGES

1133-1137

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s13300-022-01265-5

DOI

http://dx.doi.org/10.1007/s13300-022-01265-5

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1147731741

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/35532859


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Endocrinology, Bharti Hospital, 132001, Karnal, India", 
          "id": "http://www.grid.ac/institutes/grid.470178.d", 
          "name": [
            "Department of Endocrinology, Bharti Hospital, 132001, Karnal, India"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kalra", 
        "givenName": "Sanjay", 
        "id": "sg:person.01043565050.89", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01043565050.89"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Baker Heart and Diabetes Institute, Melbourne, VIC, Australia", 
          "id": "http://www.grid.ac/institutes/grid.1051.5", 
          "name": [
            "Department of Endocrinology, Diabetes and Metabolism, Christian Medical College, Vellore, India", 
            "Baker Heart and Diabetes Institute, Melbourne, VIC, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kapoor", 
        "givenName": "Nitin", 
        "id": "sg:person.01052357650.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01052357650.06"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s13300-021-01201-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1144777213", 
          "https://doi.org/10.1007/s13300-021-01201-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s13300-021-01113-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1139733137", 
          "https://doi.org/10.1007/s13300-021-01113-y"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2022-05-07", 
    "datePublishedReg": "2022-05-07", 
    "description": "Glucagon-like peptide 1 receptor agonists (GLP1RAs) have recently gained momentum after the introduction of semaglutide, the first oral molecule in their class. In a recent article in this journal by Evans et\u00a0al., a succinct overview of the utility of semaglutide is highlighted in the context of virtual diabetes care. To take this discussion further, this commentary describes the value and positioning of oral semaglutide in common clinical situations. Its insights assist in pragmatic placement of this drug in clinical practice. Special emphasis is laid on the use of oral semaglutide in persons already on injectable GLP-1RA formulations, those experiencing sudden changes in life style pattern due to religious, social, or professional commitments, individuals seeking help for urgent glycemic control, and those who face sudden change in their concomitant medications or comorbidities.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s13300-022-01265-5", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1044057", 
        "issn": [
          "1869-6953", 
          "1869-6961"
        ], 
        "name": "Diabetes Therapy", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "6", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "13"
      }
    ], 
    "keywords": [
      "oral semaglutide", 
      "glucagon-like peptide-1 receptor agonists", 
      "peptide-1 receptor agonists", 
      "common clinical situations", 
      "life-style patterns", 
      "concomitant medications", 
      "glycemic control", 
      "diabetes care", 
      "receptor agonist", 
      "oral molecules", 
      "clinical practice", 
      "semaglutide", 
      "clinical situations", 
      "comorbidities", 
      "medications", 
      "agonists", 
      "care", 
      "drugs", 
      "special situations", 
      "succinct overview", 
      "dosage", 
      "style patterns", 
      "changes", 
      "placement", 
      "persons", 
      "individuals", 
      "professional commitment", 
      "special emphasis", 
      "control", 
      "recent article", 
      "utility", 
      "use", 
      "practice", 
      "patterns", 
      "situation", 
      "overview", 
      "journals", 
      "positioning", 
      "molecules", 
      "emphasis", 
      "values", 
      "introduction", 
      "commentary", 
      "insights", 
      "sudden change", 
      "et", 
      "article", 
      "help", 
      "discussion", 
      "Evans et", 
      "formulation", 
      "class", 
      "commitment", 
      "context", 
      "al", 
      "momentum"
    ], 
    "name": "Oral Semaglutide: Dosage in Special Situations", 
    "pagination": "1133-1137", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1147731741"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s13300-022-01265-5"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "35532859"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s13300-022-01265-5", 
      "https://app.dimensions.ai/details/publication/pub.1147731741"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-08-04T17:13", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_945.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s13300-022-01265-5"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s13300-022-01265-5'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s13300-022-01265-5'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s13300-022-01265-5'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s13300-022-01265-5'


 

This table displays all metadata directly associated to this object as RDF triples.

136 TRIPLES      21 PREDICATES      82 URIs      72 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s13300-022-01265-5 schema:about anzsrc-for:11
2 anzsrc-for:1117
3 schema:author Nad0538a182d14f61ab6d4e459daa804f
4 schema:citation sg:pub.10.1007/s13300-021-01113-y
5 sg:pub.10.1007/s13300-021-01201-z
6 schema:datePublished 2022-05-07
7 schema:datePublishedReg 2022-05-07
8 schema:description Glucagon-like peptide 1 receptor agonists (GLP1RAs) have recently gained momentum after the introduction of semaglutide, the first oral molecule in their class. In a recent article in this journal by Evans et al., a succinct overview of the utility of semaglutide is highlighted in the context of virtual diabetes care. To take this discussion further, this commentary describes the value and positioning of oral semaglutide in common clinical situations. Its insights assist in pragmatic placement of this drug in clinical practice. Special emphasis is laid on the use of oral semaglutide in persons already on injectable GLP-1RA formulations, those experiencing sudden changes in life style pattern due to religious, social, or professional commitments, individuals seeking help for urgent glycemic control, and those who face sudden change in their concomitant medications or comorbidities.
9 schema:genre article
10 schema:isAccessibleForFree true
11 schema:isPartOf N2c6907ccedd64146ba73006cab0b34c9
12 N444adcc24d1b41469a82bc4ccf3e9650
13 sg:journal.1044057
14 schema:keywords Evans et
15 agonists
16 al
17 article
18 care
19 changes
20 class
21 clinical practice
22 clinical situations
23 commentary
24 commitment
25 common clinical situations
26 comorbidities
27 concomitant medications
28 context
29 control
30 diabetes care
31 discussion
32 dosage
33 drugs
34 emphasis
35 et
36 formulation
37 glucagon-like peptide-1 receptor agonists
38 glycemic control
39 help
40 individuals
41 insights
42 introduction
43 journals
44 life-style patterns
45 medications
46 molecules
47 momentum
48 oral molecules
49 oral semaglutide
50 overview
51 patterns
52 peptide-1 receptor agonists
53 persons
54 placement
55 positioning
56 practice
57 professional commitment
58 recent article
59 receptor agonist
60 semaglutide
61 situation
62 special emphasis
63 special situations
64 style patterns
65 succinct overview
66 sudden change
67 use
68 utility
69 values
70 schema:name Oral Semaglutide: Dosage in Special Situations
71 schema:pagination 1133-1137
72 schema:productId N10fb25a9245e475da837ec11417ef323
73 N6a45610507124e4eb7010cb80016334c
74 N9d777c8b54a64eeab6a8591b51fae6a0
75 schema:sameAs https://app.dimensions.ai/details/publication/pub.1147731741
76 https://doi.org/10.1007/s13300-022-01265-5
77 schema:sdDatePublished 2022-08-04T17:13
78 schema:sdLicense https://scigraph.springernature.com/explorer/license/
79 schema:sdPublisher N63aab06880a44ea6b976a71f1cfc2a0c
80 schema:url https://doi.org/10.1007/s13300-022-01265-5
81 sgo:license sg:explorer/license/
82 sgo:sdDataset articles
83 rdf:type schema:ScholarlyArticle
84 N10fb25a9245e475da837ec11417ef323 schema:name pubmed_id
85 schema:value 35532859
86 rdf:type schema:PropertyValue
87 N2c6907ccedd64146ba73006cab0b34c9 schema:volumeNumber 13
88 rdf:type schema:PublicationVolume
89 N2ce38ca01b084468bc7fe22b02bc4322 rdf:first sg:person.01052357650.06
90 rdf:rest rdf:nil
91 N444adcc24d1b41469a82bc4ccf3e9650 schema:issueNumber 6
92 rdf:type schema:PublicationIssue
93 N63aab06880a44ea6b976a71f1cfc2a0c schema:name Springer Nature - SN SciGraph project
94 rdf:type schema:Organization
95 N6a45610507124e4eb7010cb80016334c schema:name dimensions_id
96 schema:value pub.1147731741
97 rdf:type schema:PropertyValue
98 N9d777c8b54a64eeab6a8591b51fae6a0 schema:name doi
99 schema:value 10.1007/s13300-022-01265-5
100 rdf:type schema:PropertyValue
101 Nad0538a182d14f61ab6d4e459daa804f rdf:first sg:person.01043565050.89
102 rdf:rest N2ce38ca01b084468bc7fe22b02bc4322
103 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
104 schema:name Medical and Health Sciences
105 rdf:type schema:DefinedTerm
106 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
107 schema:name Public Health and Health Services
108 rdf:type schema:DefinedTerm
109 sg:journal.1044057 schema:issn 1869-6953
110 1869-6961
111 schema:name Diabetes Therapy
112 schema:publisher Springer Nature
113 rdf:type schema:Periodical
114 sg:person.01043565050.89 schema:affiliation grid-institutes:grid.470178.d
115 schema:familyName Kalra
116 schema:givenName Sanjay
117 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01043565050.89
118 rdf:type schema:Person
119 sg:person.01052357650.06 schema:affiliation grid-institutes:grid.1051.5
120 schema:familyName Kapoor
121 schema:givenName Nitin
122 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01052357650.06
123 rdf:type schema:Person
124 sg:pub.10.1007/s13300-021-01113-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1139733137
125 https://doi.org/10.1007/s13300-021-01113-y
126 rdf:type schema:CreativeWork
127 sg:pub.10.1007/s13300-021-01201-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1144777213
128 https://doi.org/10.1007/s13300-021-01201-z
129 rdf:type schema:CreativeWork
130 grid-institutes:grid.1051.5 schema:alternateName Baker Heart and Diabetes Institute, Melbourne, VIC, Australia
131 schema:name Baker Heart and Diabetes Institute, Melbourne, VIC, Australia
132 Department of Endocrinology, Diabetes and Metabolism, Christian Medical College, Vellore, India
133 rdf:type schema:Organization
134 grid-institutes:grid.470178.d schema:alternateName Department of Endocrinology, Bharti Hospital, 132001, Karnal, India
135 schema:name Department of Endocrinology, Bharti Hospital, 132001, Karnal, India
136 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...